Evidence map›Paper›PMID 33534838›Full record

ArticlePloS one2021

Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection.

Thomas G W Graham, Claire Dugast-Darzacq, Gina M Dailey, Xammy H Wrynla, Erik Van Dis, Meagan N Esbin, Abrar Abidi, Sarah A Stanley, Xavier Darzacq, Robert Tjian

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas G W GrahamDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0001-5189-4313
Claire Dugast-DarzacqDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0001-8602-3534
Gina M DaileyDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.
Xammy H WrynlaDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-7532-8356
Erik Van DisDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0003-4773-379X
Meagan N EsbinDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-2157-3831
Abrar AbidiDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.
Sarah A StanleyDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.
Xavier DarzacqDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.
Robert TjianDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0003-0539-8217

Funding

MOLECULAR BIOPHYSICS TRAINING GRANTT32GM008295 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI HURLEY, JAMES H, WEMMER, DAVID E · 1989 to 2022
$8.1M
Stem Cell Engineering Training ProgramT32GM098218 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI HEALY, KEVIN EDWARD, SCHAFFER, DAVID V · 2011 to 2020
$1.8M
Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM008295NIGMS NIH HHS T32 GM098218
6 · The paper itself

Abstract

Re-opening of communities in the midst of the ongoing COVID-19 pandemic has ignited new waves of infections in many places around the world. Mitigating the risk of reopening will require widespread SARS-CoV-2 testing, which would be greatly facilitated by simple, rapid, and inexpensive testing methods. This study evaluates several protocols for RNA extraction and RT-qPCR that are simpler and less expensive than prevailing methods. First, isopropanol precipitation is shown to provide an effective means of RNA extraction from nasopharyngeal (NP) swab samples. Second, direct addition of NP swab samples to RT-qPCRs is evaluated without an RNA extraction step. A simple, inexpensive swab collection solution suitable for direct addition is validated using contrived swab samples. Third, an open-source master mix for RT-qPCR is described that permits detection of viral RNA in NP swab samples with a limit of detection of approximately 50 RNA copies per reaction. Quantification cycle (Cq) values for purified RNA from 30 known positive clinical samples showed a strong correlation (r2 = 0.98) between this homemade master mix and commercial TaqPath master mix. Lastly, end-point fluorescence imaging is found to provide an accurate diagnostic readout without requiring a qPCR thermocycler. Adoption of these simple, open-source methods has the potential to reduce the time and expense of COVID-19 testing.

Indexed as

Chemical PrecipitationCoronavirus Nucleocapsid ProteinsCOVID-19COVID-19 Nucleic Acid TestingHumansLimit of DetectionNasopharynxPhosphoproteinsReal-Time Polymerase Chain ReactionRNA, ViralSARS-CoV-2Coronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsRNA, Viral

Identifiers

PMID33534838
PMCPMC7857565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.